BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Freedberg DE, Abrams JA. Clostridium difficile infection in the community: Are proton pump inhibitors to blame? World J Gastroenterol 2013; 19(40): 6710-6713 [PMID: 24187445 DOI: 10.3748/wjg.v19.i40.6710]
URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6710.htm
Number Citing Articles
1
Wasef Na’amnih, Amos Adler, Tamar Miller-Roll, Dani Cohen, Yehuda Carmeli. Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical CenterInfection Control & Hospital Epidemiology 2017; 38(8): 912 doi: 10.1017/ice.2017.82
2
Kamila Mielniczuk, Mariusz Mielniczuk, Mieczysława Czerwionka-Szaflarska. Ocena zależności między stosowaniem inhibitorów pompy protonowej a występowaniem uczulenia na wybrane alergeny pokarmowePediatria Polska 2014; 89(5): 352 doi: 10.1016/j.pepo.2014.03.012
3
Lauren E. Bloomfield, Thomas V. Riley. Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative ReviewInfectious Diseases and Therapy 2016; 5(3): 231 doi: 10.1007/s40121-016-0117-y
4
Robert J. Stachler, David O. Francis, Seth R. Schwartz, Cecelia C. Damask, German P. Digoy, Helene J. Krouse, Scott J. McCoy, Daniel R. Ouellette, Rita R. Patel, Charles (Charlie) W. Reavis, Libby J. Smith, Marshall Smith, Steven W. Strode, Peak Woo, Lorraine C. Nnacheta. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)Otolaryngology–Head and Neck Surgery 2018; 158(S1) doi: 10.1177/0194599817751030
5
Cynthia Lin, Timothy Wade, Elizabeth Hilborn. Flooding and Clostridium difficile Infection: A Case-Crossover AnalysisInternational Journal of Environmental Research and Public Health 2015; 12(6): 6948 doi: 10.3390/ijerph120606948
6
A. Durovic, A.F. Widmer, S. Tschudin-Sutter. New insights into transmission of Clostridium difficile infection—narrative reviewClinical Microbiology and Infection 2018; 24(5): 483 doi: 10.1016/j.cmi.2018.01.027